Drug Delivery in France

Summary

Drug Delivery in France industry profile is an essential resource for top-level data and analysis covering the drug delivery industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.

Scope

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry's prospects, competitive landscape and leading companies
• Includes a five-year forecast of the industry
• Supported by the key macroeconomic and demographic data affecting the market

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

Drug delivery systems are mechanisms by which therapeutic agents are introduced into the body, and directed in a controlled way towards a target organ or site of action. Conventional drug delivery forms are simple oral, topical, inhaled or injection formulations. More sophisticated delivery systems take into account pharmacokinetic principles, specific drug characteristics and variability of response between one individual and another, and within the same individual under different conditions. The market value in this report reflects revenues generated through the sale or licensing of drug delivery systems. Any currency conversions used in the creation of this report have been calculated using constant 2004 annual average exchange rates.

For the purposes of this report, Europe consists of France, Germany, the UK, Belgium, Italy, the Netherlands, Spain, Austria, the Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Norway, Poland, Portugal, Russia, Sweden, Switzerland and Turkey.

Content